Morfinesulfaat Sandoz (Morphine Sulfate Pentahydrate)

Morfinesulfaat Sandoz is an opioid analgesic used to manage pain conditions that involve the central nervous system.

• Acute postoperative pain: reduces pain intensity after surgical procedures.
• Cancer‑related pain: provides relief for moderate to severe malignant disease pain.
• Chronic severe non‑cancer pain: alleviates persistent pain when other therapies are insufficient.

• Morphine sulfate pentahydrate acts as a full agonist at mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces neuronal excitability, and decreases the release of neurotransmitters involved in pain transmission, resulting in analgesia and sedation.

Morfinesulfaat Sandoz may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements and hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Vomiting: expulsion of stomach contents.
• Itching: mild skin pruritus.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Anaphylactic reaction: sudden, severe allergic response.
• Adrenal insufficiency: impaired cortisol production.
• Seizures: rare occurrence of convulsive episodes.
• Dependence or addiction: potential for misuse with prolonged use.

When prescribing Morfinesulfaat Sandoz, clinicians should consider several safety measures.

• Assess respiratory function: monitor breathing rate and depth, especially during initiation or dose changes.
• Evaluate renal and hepatic status: adjust use in patients with impaired kidney or liver function.
• Monitor for signs of dependence: watch for tolerance, withdrawal, or misuse behaviors.
• Use caution in the elderly: start with lower doses due to increased sensitivity.
• Avoid concomitant CNS depressants: limit use with benzodiazepines, alcohol, or similar agents.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Morfinesulfaat Sandoz can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): may cause profound respiratory depression.
• MAO inhibitors (e.g., phenelzine, tranylcypromine): can precipitate severe hypertension or serotonin syndrome.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase morphine plasma concentrations.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.
• Other opioids: additive sedation and respiratory effects.
• Antihistamines: may enhance drowsiness.
• Diuretics: can potentiate hypotensive effects.